A survey of the kinome pharmacopeia reveals multiple scaffolds and targets for the development of novel anthelmintics
Abstract Over one billion people are currently infected with a parasitic nematode. Symptoms can include anemia, malnutrition, developmental delay, and in severe cases, death. Resistance is emerging to the anthelmintics currently used to treat nematode infection, prompting the need to develop new ant...
Guardado en:
Autores principales: | Jessica Knox, Nicolas Joly, Edmond M. Linossi, José A. Carmona-Negrón, Natalia Jura, Lionel Pintard, William Zuercher, Peter J. Roy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0e282a9e8e24d77b3d9aefd33a45006 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacopeia and Anvisa: a necessary symbiosis
por: Luís Mauricio T. R. Lima
Publicado: (2019) -
Rainforest pharmacopeia in Madagascar provides high value for current local and prospective global uses.
por: Christopher D Golden, et al.
Publicado: (2012) -
Anthelmintic resistance and homeostatic plasticity (Brugia malayi)
por: Sudhanva S. Kashyap, et al.
Publicado: (2021) -
Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
por: Ghazanfar Abbas, et al.
Publicado: (2021) -
Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
por: Runjun D. Kumar, et al.
Publicado: (2017)